Ignite Creation Date:
2024-05-06 @ 6:01 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05514873
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-16
First Post:
2022-08-22
Brief Title:
An Open-label Study to Evaluate the Safety Tolerability and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Generalized Myasthenia Gravis |
Keywords:
| Name | View |
|---|---|
| gMG | View |